| Copper | Approved Investigational | BBS12 | 166379 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of BBS12 mRNA | 4q27 | |
| Copper | Approved Investigational | BBS2 | 583 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of BBS2 mRNA | 16q13 | |
| Copper | Approved Investigational | BCAN | 63827 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of BCAN mRNA | 1q23.1 | |
| Copper | Approved Investigational | BCCIP | 56647 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of BCCIP mRNA | 10q26.2 | |
| Copper | Approved Investigational | BCHE | 590 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of BCHE mRNA | 3q26.1 | |
| Copper | Approved Investigational | BCKDK | 10295 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of BCKDK mRNA | 16p11.2 | |
| Copper | Approved Investigational | BCL11A | 53335 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of BCL11A mRNA | 2p16.1 | |
| Copper | Approved Investigational | BCL2 | 596 |
downregulated | Copper results in decreased expression of BCL2 mRNA | 18q21.33 | |
| Copper | Approved Investigational | BDH1 | 622 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of BDH1 mRNA | 3q29 | |
| Copper | Approved Investigational | BDNF | 627 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of BDNF mRNA | 11p14.1 | |
| Copper | Approved Investigational | BEND4 | 389206 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of BEND4 mRNA | 4p13 | |
| Copper | Approved Investigational | BEX2 | 84707 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of BEX2 mRNA | Xq22.2 | |
| Copper | Approved Investigational | BEX3 | 27018 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of BEX3 mRNA | Xq22.2 | |
| Copper | Approved Investigational | BID | 637 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of BID mRNA | 22q11.21 | |
| Copper | Approved Investigational | BIRC5 | 332 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of BIRC5 mRNA | 17q25.3 | |
| Copper | Approved Investigational | BIVM | 54841 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of BIVM mRNA | 13q33.1 | |
| Copper | Approved Investigational | BLM | 641 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of BLM mRNA | 15q26.1 | |
| Copper | Approved Investigational | BLVRB | 645 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of BLVRB mRNA | 19q13.2 | |
| Copper | Approved Investigational | BLZF1 | 8548 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of BLZF1 mRNA | 1q24.2 | |
| Copper | Approved Investigational | BNIP3L | 665 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of BNIP3L mRNA | 8p21.2 | |
| Copper | Approved Investigational | BRAT1 | 221927 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of BRAT1 mRNA | 7p22.3 | |
| Copper | Approved Investigational | BRF2 | 55290 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of BRF2 mRNA | 8p11.23 | |
| Copper | Approved Investigational | BRI3BP | 140707 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of BRI3BP mRNA | 12q24.31 | |
| Copper | Approved Investigational | BTG1 | 694 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of BTG1 mRNA | 12q21.33 | |
| Copper | Approved Investigational | BTK | 695 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of BTK mRNA | Xq22.1 | |